Area of research
Radiology, Nuclear Medicine and Imaging · Cancer Research
Research interest
Research interests include Effects of Radiation Exposure, Cancer-related molecular mechanisms research, Occupational and environmental lung diseases, and Gut microbiota and health.
A phase II trial comparing dalpiciclib in combination with letrozole versus standard chemotherapy as neoadjuvant therapy in patients with high-risk HR- positive HER-2 negative breast cancer: DARLING-02.
Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models
Pyrotinib combined with EC-TH neoadjuvant therapy for patients with HER2-positive breast cancer: A multicenter, randomized, phase II, open-label trial.
DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer